Nomura Holdings Inc. Purchases Shares of 10,754 ICU Medical, Inc. $ICUI

Key Points

• Nomura Holdings Inc. has acquired 10,754 shares of ICU Medical, valued at approximately $1.49 million, as reported in its recent 13F filing with the SEC.
• Insider buying activities included CEO Vivek Jain purchasing 21,929 shares for about $2.47 million, indicating significant confidence in the company's prospects.
• ICU Medical recently reported earnings of $2.10 per share, exceeding expectations, despite an 8% decline in revenue year-over-year.

Nomura Holdings Inc. purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,754 shares of the medical instruments supplier's stock, valued at approximately $1,493,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Xponance Inc. boosted its position in ICU Medical by 5.3% in the first quarter. Xponance Inc. now owns 1,714 shares of the medical instruments supplier's stock valued at $238,000 after buying an additional 86 shares in the last quarter. Blue Trust Inc. lifted its position in shares of ICU Medical by 23.0% during the first quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock worth $111,000 after purchasing an additional 150 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of ICU Medical by 27.2% during the first quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 153 shares in the last quarter. Vise Technologies Inc. lifted its position in shares of ICU Medical by 7.1% during the fourth quarter. Vise Technologies Inc. now owns 2,649 shares of the medical instruments supplier's stock worth $411,000 after purchasing an additional 176 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ICU Medical by 4.1% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,204 shares of the medical instruments supplier's stock worth $1,894,000 after purchasing an additional 478 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at ICU Medical

In other news, Director David C. Greenberg bought 1,200 shares of the stock in a transaction on Wednesday, August 27th. The stock was purchased at an average price of $126.42 per share, with a total value of $151,704.00. Following the completion of the purchase, the director owned 7,960 shares of the company's stock, valued at approximately $1,006,303.20. This trade represents a 17.75% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Vivek Jain bought 21,929 shares of the stock in a transaction on Thursday, August 14th. The stock was purchased at an average cost of $112.84 per share, with a total value of $2,474,468.36. Following the purchase, the chief executive officer directly owned 130,149 shares of the company's stock, valued at approximately $14,686,013.16. This represents a 20.26% increase in their position. The disclosure for this purchase can be found here. 1.50% of the stock is currently owned by corporate insiders.

ICU Medical Trading Down 0.5%

Shares of NASDAQ ICUI opened at $127.02 on Wednesday. The company's 50 day simple moving average is $126.78 and its 200 day simple moving average is $135.35. ICU Medical, Inc. has a fifty-two week low of $107.00 and a fifty-two week high of $196.26. The firm has a market capitalization of $3.14 billion, a P/E ratio of -83.57 and a beta of 0.86. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.44 and a quick ratio of 1.17.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.66. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The business had revenue of $543.57 million for the quarter, compared to analyst estimates of $543.33 million. During the same period in the prior year, the business posted $1.56 earnings per share. ICU Medical's revenue was down 8.0% compared to the same quarter last year. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. On average, analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on ICUI shares. Wall Street Zen lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Piper Sandler started coverage on shares of ICU Medical in a research report on Friday, August 15th. They set an "overweight" rating and a $145.00 target price on the stock. Finally, Raymond James Financial reduced their target price on shares of ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating on the stock in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus price target of $179.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.